768 related articles for article (PubMed ID: 20080426)
1. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program.
Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL
Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients.
Momosaki K; Kido J; Yoshida S; Sugawara K; Miyamoto T; Inoue T; Okumiya T; Matsumoto S; Endo F; Hirose S; Nakamura K
J Hum Genet; 2019 Aug; 64(8):741-755. PubMed ID: 31076647
[TBL] [Abstract][Full Text] [Related]
3. Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots.
Shigeto S; Katafuchi T; Okada Y; Nakamura K; Endo F; Okuyama T; Takeuchi H; Kroos MA; Verheijen FW; Reuser AJ; Okumiya T
Mol Genet Metab; 2011 May; 103(1):12-7. PubMed ID: 21320792
[TBL] [Abstract][Full Text] [Related]
4. High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population.
Kumamoto S; Katafuchi T; Nakamura K; Endo F; Oda E; Okuyama T; Kroos MA; Reuser AJ; Okumiya T
Mol Genet Metab; 2009 Jul; 97(3):190-5. PubMed ID: 19362502
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for Pompe disease in Japan.
Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
[TBL] [Abstract][Full Text] [Related]
6. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
7. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing lysosomal storage disorders: Pompe disease.
Bodamer OA; Dajnoki A
Curr Protoc Hum Genet; 2012 Oct; Chapter 17():Unit17.11. PubMed ID: 23074069
[TBL] [Abstract][Full Text] [Related]
9. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
[TBL] [Abstract][Full Text] [Related]
10. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
11. The genotype-phenotype correlation in Pompe disease.
Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
[TBL] [Abstract][Full Text] [Related]
12. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
[TBL] [Abstract][Full Text] [Related]
13. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.
Lin N; Huang J; Violante S; Orsini JJ; Caggana M; Hughes EE; Stevens C; DiAntonio L; Chieh Liao H; Hong X; Ghomashchi F; Babu Kumar A; Zhou H; Kornreich R; Wasserstein M; Gelb MH; Yu C
Clin Chem; 2017 Apr; 63(4):842-851. PubMed ID: 28196920
[TBL] [Abstract][Full Text] [Related]
14. p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?
Kroos MA; Mullaart RA; Van Vliet L; Pomponio RJ; Amartino H; Kolodny EH; Pastores GM; Wevers RA; Van der Ploeg AT; Halley DJ; Reuser AJ
Eur J Hum Genet; 2008 Aug; 16(8):875-9. PubMed ID: 18301443
[TBL] [Abstract][Full Text] [Related]
15. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
[TBL] [Abstract][Full Text] [Related]
16. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM
Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590
[TBL] [Abstract][Full Text] [Related]
17. Pompe disease ascertained through The Lantern Project, 2018-2021: Next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis.
Sniderman King L; Pan Y; Nallamilli BRR; Hegde M; Jagannathan L; Ramachander V; Lucas A; Markind J; Colzani R
Mol Genet Metab; 2023 May; 139(1):107565. PubMed ID: 37087815
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening for Pompe disease: an update, 2011.
Burton BK
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
[TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease.
Liao HC; Chan MJ; Yang CF; Chiang CC; Niu DM; Huang CK; Gelb MH
Clin Chem; 2017 Jul; 63(7):1271-1277. PubMed ID: 28450385
[TBL] [Abstract][Full Text] [Related]
20. Pompe disease: early diagnosis and early treatment make a difference.
Chien YH; Hwu WL; Lee NC
Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
